PDA

View Full Version : Pharmacutical Innovation is Over



Nubs
03-24-2010, 02:44 PM
The stated aim of thid administration is to reduce the profits of "Big Pharma" by $90B over the next 10 years. R&D will be the first place they stop. Eventhough the limits don't kick in for 4 years, and pharma stocks are soaring for the moment, just watch how many layoff from R&D are to follow soon. If it takes 10-20 years to bring a drug to market from concept, I see pharma immediately beginning to wind down R&D activities.

wilbur
03-24-2010, 03:28 PM
The stated aim of thid administration is to reduce the profits of "Big Pharma" by $90B over the next 10 years. R&D will be the first place they stop. Eventhough the limits don't kick in for 4 years, and pharma stocks are soaring for the moment, just watch how many layoff from R&D are to follow soon. If it takes 10-20 years to bring a drug to market from concept, I see pharma immediately beginning to wind down R&D activities.

Things like new strains of bacteria resistant to drugs have already caused the drug companies to move away from spending R&D creating life saving, and much needed, antibiotics. They don't want to spend the R&D, and approval process time working on drugs that might be obsolete in only a few years, due to resistance - they spend their time thinking up new high profit "life enhancers" like Viagra. Actual medicine is falling by the wayside - so good riddance to them.

Wei Wu Wei
03-24-2010, 03:36 PM
The Manhattan Project
The Human Genome Project

Wei Wu Wei
03-24-2010, 03:38 PM
The stated aim of thid administration is to reduce the profits of "Big Pharma" by $90B over the next 10 years. R&D will be the first place they stop. Eventhough the limits don't kick in for 4 years, and pharma stocks are soaring for the moment, just watch how many layoff from R&D are to follow soon. If it takes 10-20 years to bring a drug to market from concept, I see pharma immediately beginning to wind down R&D activities.

Yes their profits are just gonna slam through the basement when everyone is required to buy their product.